You are here: Industry Insights > NHS

News List

Scotland approves NHS funding for Ibrance, Cerdelga and Invicorp pharmatimes
December 13, 2017
The latest batch of decisions by the Scottish Medicines Consortium has given patients with certain forms of breast cancer, Gaucher disease and erectile dysfunction new treatment options on the NHS.
NHS talking therapies for mental health hit a high with 1.4 million referrals pharmafile
December 06, 2017
New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, with 1.4 million new referrals and 965,000 people starting treatment in 2016/17 – an increase of 32,000 on the previous year.
NHS A&E performance target remains well under par pharmatimes
December 05, 2017
December has kicked off with NHS hospital performance against the four hour A&E target standing at just 82.45 percent - 12.55 percentage points lower than the 95 percent standard, reports the Royal College of Emergency Medicine (RCEM).
UK regulator accuses Concordia of overcharging NHS for thyroid drug pharmaceutical-business
November 24, 2017
The UK Competition and Markets Authority (CMA) has accused Canadian pharma company Concordia International of abusing its dominant position by increasing the price of a thyroid drug by about 6,000%.
Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds biospace
November 23, 2017
Concordia International, the Canadian drug company, has overcharged the NHS by more than £100m in the past decade for a life-changing thyroid drug, according to Britain’s competition watchdog.
NHS England consults on simplifying research processes pharmatimes
November 22, 2017
NHS England says it is planning to accelerate the NHS’ national research strategy, “cutting bureaucracy and speeding up access to new and innovative treatments”.
NHS faced with 5,700% increase in drug price, finds CMA pharmafile
November 22, 2017
The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of an essential medicine by 5,711%.
Health bodies test digital interventions for diabetes pharmatimes
November 16, 2017
NHS England, Public Health England and Diabetes UK have teamed up with leading companies from the tech sector to test new digital approaches to fighting type II diabetes.
NHS backs innovative means of cutting diabetes risk pharmafile
November 16, 2017
It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk of developing type 2 diabetes. It was revealed that more than 5,000 people will be enrolled to test apps tracking physical activity and other health
Scotland approves three new meds for NHS use pharmatimes
November 15, 2017
The Scottish Medicines Consortium (SMC) has published new advice accepting three new medicines for use by NHS Scotland, offering patients new treatment options for soft tissue sarcoma, acromegaly and hepatitis C.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page